KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Current Taxes (2016 - 2025)

Astrana Health's Current Taxes history spans 11 years, with the latest figure at $4.9 million for Q3 2025.

  • For Q3 2025, Current Taxes changed N/A year-over-year to $4.9 million; the TTM value through Sep 2025 reached $4.9 million, changed N/A, while the annual FY2024 figure was $11.0 million, N/A changed from the prior year.
  • Current Taxes for Q3 2025 was $4.9 million at Astrana Health, down from $19.4 million in the prior quarter.
  • Across five years, Current Taxes topped out at $30.1 million in Q3 2023 and bottomed at $2.2 million in Q2 2021.
  • The 5-year median for Current Taxes is $6.8 million (2023), against an average of $10.6 million.
  • The largest annual shift saw Current Taxes crashed 94.75% in 2021 before it skyrocketed 64.79% in 2023.
  • A 5-year view of Current Taxes shows it stood at $4.0 million in 2021, then rose by 6.34% to $4.3 million in 2022, then soared by 603.72% to $30.1 million in 2023, then plummeted by 63.33% to $11.0 million in 2024, then crashed by 55.45% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Current Taxes are $4.9 million (Q3 2025), $19.4 million (Q2 2025), and $11.0 million (Q4 2024).